📋 FDA Reference

Penumbra Ddc Catheters

Penumbra, Inc.

Ask about this device Compare similar devices

Summary: The Penumbra DDC Catheters are used for mechanical thrombectomy in venous systems, often by interventional radiologists or vascular surgeons.

FDA Clearance Information

Pathway ? 510(k)
Number ? K122772 ↗
Decision Date ? November 20, 2012
Product Code ? DQY Catheter, Percutaneous
Device Class ? Class 2
Evidence ? 0 studies

The Penumbra DDC Catheters were cleared via the FDA 510k pathway on November 20, 2012. Manufactured by Penumbra, this Class 2 device is classified under product code DQY.

What It Is

The Penumbra DDC Catheters are specialized medical devices designed for mechanical thrombectomy procedures. They work by navigating through the venous system to remove thrombi, or blood clots, using suction or other mechanical means. These catheters are essential tools in treating conditions like deep vein thrombosis, where clot removal is necessary to restore normal blood flow.

FDA-Cleared Indications

  • Percutaneous removal of thrombus from blood vessels when catheter-based treatment is indicated.
  • Use in the vascular system under imaging guidance by appropriately trained clinicians.
  • The specific indication, anatomy, catheter size, and technique must be confirmed in the applicable Penumbra instructions for use.

Clinical Applications

  • Catheter-based thrombectomy for selected deep vein thrombosis cases when the device labeling and anatomy are appropriate.
  • Thrombectomy of selected thrombosed dialysis grafts or fistulas, when covered by the applicable device labeling.
  • Removal of thrombus from a treated venous segment as part of an endovascular procedure.
  • Use with venography or other vascular imaging to guide catheter positioning and assess blood-flow restoration.

Reported off-label uses

  • Use in selected pulmonary embolism thrombectomy procedures may be reported in clinical practice, but the applicable device-specific labeling should be checked before use.
  • Use in other venous territories or clot burdens outside the cleared indication may occur in practice but should not be assumed to be FDA-cleared.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Practical Considerations

  • Select catheter diameter and length based on the target vessel, clot burden, access route, and compatibility with guidewires, sheaths, and any aspiration or thrombectomy system used.
  • Access is commonly obtained through a peripheral vein, dialysis access circuit, or another vascular entry site, with fluoroscopy and contrast venography used for navigation and assessment.
  • The procedure may involve local anesthesia with moderate sedation or, in selected cases, general anesthesia; duration and hospital stay depend on the clot location and the patient's condition.
  • Review the current instructions for use for contraindications, vessel-size requirements, pressure limits, compatibility, and warnings about perforation, bleeding, embolization, and device malfunction.
  • MRI safety is device- and configuration-specific. Do not assume the catheter or any retained component is MR Safe or MR Conditional without checking the current labeling.

Procedures that use this device

Frequently Asked Questions

What is Penumbra DDC Catheters used for?

The device is used for mechanical thrombectomy to remove blood clots from the venous system.

What specialties typically use this device?

Interventional radiologists and vascular surgeons commonly use this device in hospital settings.

What are the FDA-cleared indications?

The device is indicated for mechanical thrombectomy in patients with venous thromboembolic disorders.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you